Literature DB >> 20200027

Acellular pertussis vaccination facilitates Bordetella parapertussis infection in a rodent model of bordetellosis.

Gráinne H Long1, Alexia T Karanikas, Eric T Harvill, Andrew F Read, Peter J Hudson.   

Abstract

Despite over 50 years of population-wide vaccination, whooping cough incidence is on the rise. Although Bordetella pertussis is considered the main causative agent of whooping cough in humans, Bordetella parapertussis infections are not uncommon. The widely used acellular whooping cough vaccines (aP) are comprised solely of B. pertussis antigens that hold little or no efficacy against B. parapertussis. Here, we ask how aP vaccination affects competitive interactions between Bordetella species within co-infected rodent hosts and thus the aP-driven strength and direction of in-host selection. We show that aP vaccination helped clear B. pertussis but resulted in an approximately 40-fold increase in B. parapertussis lung colony-forming units (CFUs). Such vaccine-mediated facilitation of B. parapertussis did not arise as a result of competitive release; B. parapertussis CFUs were higher in aP-relative to sham-vaccinated hosts regardless of whether infections were single or mixed. Further, we show that aP vaccination impedes host immunity against B. parapertussis-measured as reduced lung inflammatory and neutrophil responses. Thus, we conclude that aP vaccination interferes with the optimal clearance of B. parapertussis and enhances the performance of this pathogen. Our data raise the possibility that widespread aP vaccination can create hosts more susceptible to B. parapertussis infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20200027      PMCID: PMC2880100          DOI: 10.1098/rspb.2010.0010

Source DB:  PubMed          Journal:  Proc Biol Sci        ISSN: 0962-8452            Impact factor:   5.349


  49 in total

1.  Influenza: the new acquayantance.

Authors:  T FRANCIS
Journal:  Ann Intern Med       Date:  1953-08       Impact factor: 25.391

2.  Analysis of Bordetella pertussis populations in European countries with different vaccination policies.

Authors:  S C M van Amersfoorth; L M Schouls; H G J van der Heide; A Advani; H O Hallander; K Bondeson; C H W von König; M Riffelmann; C Vahrenholz; N Guiso; V Caro; E Njamkepo; Q He; J Mertsola; F R Mooi
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

Review 3.  Improving pertussis vaccination.

Authors:  Guy A M Berbers; Sabine C de Greeff; Frits R Mooi
Journal:  Hum Vaccin       Date:  2009-07-08

4.  Carriage of pneumococci after pneumococcal vaccination.

Authors:  S K Obaro; R A Adegbola; W A Banya; B M Greenwood
Journal:  Lancet       Date:  1996-07-27       Impact factor: 79.321

5.  The efficacy of a whole cell pertussis vaccine and fimbriae against Bordetella pertussis and Bordetella parapertussis infections in a respiratory mouse model.

Authors:  R J Willems; J Kamerbeek; C A Geuijen; J Top; H Gielen; W Gaastra; F R Mooi
Journal:  Vaccine       Date:  1998-02       Impact factor: 3.641

6.  Parapertussis and pertussis: differences and similarities in incidence, clinical course, and antibody responses.

Authors:  E Bergfors; B Trollfors; J Taranger; T Lagergård; V Sundh; G Zackrisson
Journal:  Int J Infect Dis       Date:  1999       Impact factor: 3.623

7.  Comparative phenotypic analysis of the Bordetella parapertussis isolate chosen for genomic sequencing.

Authors:  Ulrich Heininger; Peggy A Cotter; Howard W Fescemyer; Guillermo Martinez de Tejada; Ming H Yuk; Jeff F Miller; Eric T Harvill
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

8.  A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis.

Authors:  K H Mills; M Ryan; E Ryan; B P Mahon
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

9.  Bordetella parapertussis infection in children: epidemiology, clinical symptoms, and molecular characteristics of isolates.

Authors:  P Mastrantonio; P Stefanelli; M Giuliano; Y Herrera Rojas; M Ciofi degli Atti; A Anemona; A E Tozzi
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

10.  Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence?

Authors:  F R Mooi; I H van Loo; A J King
Journal:  Emerg Infect Dis       Date:  2001       Impact factor: 6.883

View more
  17 in total

Review 1.  The pertussis enigma: reconciling epidemiology, immunology and evolution.

Authors:  Matthieu Domenech de Cellès; Felicia M G Magpantay; Aaron A King; Pejman Rohani
Journal:  Proc Biol Sci       Date:  2016-01-13       Impact factor: 5.349

2.  Imperfect vaccine-induced immunity and whooping cough transmission to infants.

Authors:  Jennie Lavine; Hélène Broutin; Eric T Harvill; Ottar N Bjørnstad
Journal:  Vaccine       Date:  2010-10-27       Impact factor: 3.641

3.  Bordetella parapertussis survives inside human macrophages in lipid raft-enriched phagosomes.

Authors:  Juan Gorgojo; Eric T Harvill; Maria Eugenia Rodríguez
Journal:  Infect Immun       Date:  2014-09-29       Impact factor: 3.441

4.  Bordetella parapertussis survives the innate interaction with human neutrophils by impairing bactericidal trafficking inside the cell through a lipid raft-dependent mechanism mediated by the lipopolysaccharide O antigen.

Authors:  Juan Gorgojo; Yanina Lamberti; Hugo Valdez; Eric T Harvill; Maria Eugenia Rodríguez
Journal:  Infect Immun       Date:  2012-10-01       Impact factor: 3.441

5.  Enhancement of Bordetella parapertussis infection by Bordetella pertussis in mixed infection of the respiratory tract.

Authors:  Zoë E V Worthington; Nico Van Rooijen; Nicholas H Carbonetti
Journal:  FEMS Immunol Med Microbiol       Date:  2011-07-29

6.  The Adjuvant Bordetella Colonization Factor A Attenuates Alum-Induced Th2 Responses and Enhances Bordetella pertussis Clearance from Mouse Lungs.

Authors:  Jamie Jennings-Gee; Sally Quataert; Tridib Ganguly; Ralph D'Agostino; Rajendar Deora; Purnima Dubey
Journal:  Infect Immun       Date:  2018-05-22       Impact factor: 3.441

7.  Widespread Bordetella parapertussis Infections-Wisconsin, 2011-2012: Clinical and Epidemiologic Features and Antibiotic Use for Treatment and Prevention.

Authors:  Ruth Koepke; Michael L Bartholomew; Jens C Eickhoff; Roman A Ayele; Diane Rodd; Joan Kuennen; Jean Rosekrans; David M Warshauer; James H Conway; Jeffrey P Davis
Journal:  Clin Infect Dis       Date:  2015-06-25       Impact factor: 9.079

8.  Pertussis outbreak, southeastern Minnesota, 2012.

Authors:  Alexander G Theofiles; Scott A Cunningham; Nicholas Chia; Patricio R Jeraldo; Daniel J Quest; Jayawant N Mandrekar; Robin Patel
Journal:  Mayo Clin Proc       Date:  2014-10       Impact factor: 7.616

9.  Bordetella parapertussis outbreak in Bisham, Pakistan in 2009-2010: fallout of the 9/11 syndrome.

Authors:  S Javed; F Said; S A M A S Eqani; H Bokhari
Journal:  Epidemiol Infect       Date:  2015-01-13       Impact factor: 4.434

Review 10.  An ecological and conservation perspective on advances in the applied virology of zoonoses.

Authors:  Kurt J Vandegrift; Nina Wale; Jonathan H Epstein
Journal:  Viruses       Date:  2011-04-15       Impact factor: 5.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.